A recombinant vaccinia virus vector was constructed which expressed the major surface glycoprotein G of human respiratory syncytial virus (RSV) and the thymidine kinase (tk) gene of vaccinia virus. The virulence of this tk ÷ recombinant virus was compared with that of a tk-recombinant and the wild-type (wt) virus after intranasal inoculation of mice. Respiratory infection with wt virus resulted in a lethal infection with widespread dissemination of virus. In contrast, infection with the tk-recombinant was not lethal and the virus had a reduced ability to disseminate to extrapulmonary tissue compared with wt virus. Insertion of the tk gene restored the virulence of the recombinant virus to the level of that of the wt virus. Despite a dramatic reduction in virulence of the tkrecombinant, virus could occasionally be recovered from the brains of mice. The expression of the attachment glycoprotein of RSV appeared to enhance the ability of the tk-recombinant virus to replicate in the lungs when compared with recombinants expressing fusion or nucleoprotein genes. The results confirm that inactivation of the tk gene results in a dramatic reduction of virulence for mice but suggest that there is still a potential danger of infection of the brain following intranasal administration of virus.
Introduction
Recombinant vaccinia virus (VV) expressing foreign genes has proved to be effective in inducing protective immunity to a number of different infectious agents (Smith et al., 1983a, b; Cremer et al., 1985; Stott et al., 1987) . Despite their apparent efficacy, a major concern about the use of live VV recombinants as vaccines lies in the potential for complications such as post-vaccinial encephalitis (Kaplan, 1989) . Animal studies have therefore been carried out to compare the virulence of VV recombinants with that of the parental wild-type (wt) virus. Such studies have shown that recombinant VV in which the thymidine kinase (tk) gene is inactivated by the insertion of foreign genes have dramatically reduced virulence in mice when inoculated by the intracerebral and intraperitoneal (i.p.) routes (Buller et al., 1985) . Following i.p. inoculation, tk-recombinants have a decreased ability to disseminate to, and/or replicate in, the internal organs and brains of mice. Since tkrecombinant viruses replicate locally to a level similar to that of wt virus after intradermal scarification, these findings suggest that any recombinants reaching the bloodstream after scarification would not replicate as well as the wt in spleen and liver. Consequently, the secondary viraemia would be of a lower magnitude and this would reduce the likelihood of VV-associated complications.
One problem with such studies is that during the derivation of tk-recombinants, by selection of virus plaques in the presence of 5-bromo-2'-deoxy uridine, mutations might occur which could contribute to the reduced virulence of the recombinant virus. The present studies were therefore undertaken to determine whether reinsertion of the tk gene into a recombinant VV could restore virulence for mice. Differences in virulence between the parent VV strain, WR, and tk-and tk ÷ recombinants expressing the G glycoprotein of respiratory syncytial virus (RSV) were examined by comparing the levels of virus infectivity in various tissues following intranasal (i.n.) inoculation of BALB/c mice. This route was chosen because it has been suggested that vaccination by the i.n. route may be desirable for the induction of protective immunity throughout the entire respiratory tract. Thus, i.n. inoculation of mice with recombinant VV expressing the influenza virus haemagglutinin gene conferred protection against influenza infection on both the upper and lower respiratory tract whereas intrader-0000-9741 © 199l SGM mal vaccination protected only the lower respiratory tract (Small et al., 1985) . Furthermore, it has been reported that the i.n. route of vaccination overcomes the immunosuppressive effects of passively acquired antibody (Murphy et al., 1989) . The possibility that surface proteins encoded by foreign genes in the recombinants may alter the tissue tropism of the virus was also examined.
Methods
Viruses and cells. The construction and characterization of VV (strain WR) recombinants vG301, vN333 and vF317, which contain, respectively, the genes for the large glycoprotein (G), the nucleocapsid protein (N) and the fusion glycoprotein (F) of human RSV, have been described previously King et al., 1987; Wertz et al., 1987) .
In order to be able to reinsert the VV tk gene into vG301 without causing concomitant excision of the RSV G gene, we first constructed a version of vG301 that lacked the entire VV tk coding sequence except for the first 15 and last six base pairs of the open reading frame (ORF). This recombinant (vG301.208) was selected and plaque-purified in the presence of 5-bromo-2'-deoxyuridine as described for the other tk-VV recnmbinants . Like vG301, vG301.208 contained the RSV G gene downstream of the VV 7.5K promoter, although the orientation of the promoter with respect to the surrounding VV sequences was the reverse of that found in vG301. The expression of G from vG301.208 was indistinguishable from that described for vG301 both qualitatively and quantitatively. The tk gene was reinserted into vG301.208 at a site in the HindIII F fragment of the VV genome, about 45 kb away from its position in wt VV. An 888 bp Sau3A fragment which encompasses the promoter site, coding sequence and early transcriptional termination site of the tk gene (Ball, 1987) was ligated into the unique BamHI site of the HindIII F fragment of VV DNA, a site that is known to be non-essential for virus replication in cell culture (Panicali and Paoletti, 1982) . The resulting plasmid DNA was transfected into cells with vG301.208 and the tk + recombinants were selected with methotrexate as described before (Ball, 1987) . Analysis of the genome structure of a tk + recombinant plaque-purified five times (vG301.208 tk +) by restriction endonuclease digestion and Southern blotting showed that it retained the RSV G gene in the partially deleted HindlIl J region, and that, as intended, it contained the tk gene in the HindIII F region. Repeated passage under non-selective conditions in cell culture showed that the tk + phenotype of vG301.208 tk + was stable and measurement of the tk activity in infected cells (Hruby & Ball, 1981) showed that the kinetics and extent of tk gene expression were indistinguishable from those of wt VV.
Recombinant and wt VV were propagated in HEp-2 or CV-l cells and titrated in CV-1 or HTK cells as described previously (Stott et al., 1987) . Medium for the growth and maintenance of HEp-2 and HTK cells consisted of Eagle's MEM supplemented with 10% foetal calf serum, 2 mM-L-glutamine, 60 p.g/ml penicillin, 100 p,g/ml streptomycin, 50 units (U)/ml mycostatin, 0.14% sodium bicarbonate and 10 mM-HEPES buffer. CV-1 cells were grown in Dulbecco's MEM supplemented as above.
Mice. Specific-pathogen-free BALB/c mice of the MRC Laboratory Animal Centre's category 4 standard were obtained from Charles Rivers. Mice weighing 20 to 25 g were inoculated i.p. with 100 ~tl of virus or anaesthetized with sodium pentobarbitol and inoculated i.n. with 50 ~tl virus diluted in 10 mM-Tris-HC1 pH 8.8 as described previously (Taylor et al., 1984) .
Virus assay. At intervals after virus inoculation, mice, in groups of at least four, were killed with an overdose of sodium pentobarbitol. Blood was collected from the axilla and diluted 1 : 10 with cell culture medium containing 10 U/ml of preservative-free heparin. Samples of liver, spleen, kidney, lungs and brain were obtained and homogenized to give a 10% suspension as described previously (Taylor et al., 1984) . Care was taken to exclude possible contamination of the brain by material from the nasal passages. Virus infectivity in tissue samples was assayed on CV-1 or HTK monolayers; plates were incubated for 2 days at 37 °C. Titres of virus were expressed as loglo p.f.u./g of tissue. For each group of mice results are expressed as the mean of the virus titres of all of the mice, using values of log10 1-6 for samples from which virus was not recovered.
Results

Viral infectivity in the lungs of mice inoculated i.n. with wt VV and tk + and tk-phenotypes of vG301 recombinant
The virulence of tk-and tk + phenotypes of vG301. 208 recombinant virus was compared with that of the parental wt virus after i.n. inoculation of mice. Mice were inoculated with 105 to 5 x 105 p.f.u, of the various viruses and tissues from groups of four animals were examined at intervals up to 11 days after inoculation. Three days after infection with the wt and vG301.208 tk + virus, the animals became ill. One animal from each group died on day 6, and the remainder were killed in extremis on day 7. There was a marked consolidation of the lungs in both groups of animals, suggesting that pneumonia was the main cause of illness. In contrast, mice inoculated i.n. with 1 or 3 x l0 s p.f.u, of vG301.208 tk-remained healthy throughout the experiment.
After infection with wt and tk + strains, virus was recovered from the lungs of all animals. Peak titres of virus occurred at days 3 to 4 after infection and remained at a high level until the mice were killed in extremis on day 7 (Fig. 1) . Although the level of infectivity in the lungs of mice infected with the wt virus was only slightly greater than that in mice infected with the tk + virus, the difference was statistically significant (P<0-01). In contrast, the level of infectivity in the lungs of mice inoculated with vG301.208 tk-was 100-to 1000-fold less than that seen in animals infected with wt or tk + virus. In animals infected with vG301.208 tk-, peak titres occurred on day 4 and virus was cleared from the lungs by day 11 (Fig. 1) .
Differences in the levels of infectivity in the lungs of mice given either the tk-virus or the tk + or wt viruses were observed by 24 h after i.n. inoculation (Fig. 1) . However, in these experiments the titre of the tk-virus inoculum was slightly lower than that of the wt or tk + viruses, therefore the replication of virus in the lungs of mice inoculated i.n. with the same titre (3 × IO s p.f.u.) of tk-and tk + phenotypes was compared over the first 24 h of infection. Approximately 20~ of the inoculum was recovered from the lungs 2 h after i.n. inoculation. As seen in Fig. 2 , the titre of virus in the lungs of both groups of mice had fallen by approximately 15-fold at 12 h after inoculation. After this time there was an increase in virus titre in the lungs of animals infected with the tk + virus, so that by 24 h after infection the level of virus infectivity was similar to that seen at 2 h. In contrast, despite a slight but statistically significant (P < 0.05) increase in virus titre in the lungs of mice inoculated 18 h previously with the tk-virus, the level of infectivity in the lungs at 24 h was significantly less than that seen 2 h after inoculation (P < 0-01).
Extrapulmonary dissemination of wt and tk + and tkrecombinant viruses after i.n. inoculation
After i.n. inoculation with tk-virus there was little extrapulmonary dissemination of virus. Virus was not recovered from blood, spleen, kidney or liver at any time during 11 days after inoculation. However, virus was recovered from the brain; virus was detected in low titres in the brains of three out of four mice inoculated i.n. with vG301 7 days previously and in the brains of all four mice inoculated i.n. 4 days previously with vG301. 208 (Fig.  3) . In contrast, virus was recovered in high titres from the spleen, liver, kidney and brain of mice infected with the wt and tk ÷ viruses (Fig. 4a and b respectively) . The level of infectivity in these tissues was lower than that seen in the lung and there were no significant differences in the levels of infectivity in the kidney and brain of mice inoculated with the wt and tk ÷ viruses. However, the level of infectivity in the spleen and liver of mice inoculated with wt virus was significantly higher than that in animals inoculated with the tk ÷ virus (P < 0.001 and P<0.001 respectively). It is possible that this difference is due to the interruption of the non-essential ORF in the HindlII F fragment into which the tk gene was reintroduced. The function of the protein product of this ORF is unknown.
Replication of vG and vN recombinant viruses after i.p. and i.n. inoculation
In order to determine whether surface proteins encoded by foreign genes in the recombinants affected the ability of the virus to replicate in tissues, the ability of vG301 (Table 1) . In both groups of animals, virus was recovered more frequently from the spleen than the lung and the levels of virus replication were similar. After i.n. inoculation with vG or vN, virus grew to high titres in the lungs (Table 1) . In both groups of animals, peak titres of virus occurred in the lungs on day 4 of infection and virus was still present on day 7. The level of virus infectivity in the lungs of mice inoculated i.n. with vN and those inoculated with vG were similar for the first 3 days of infection. However, peak virus titres at day 4 were 10-fold greater in the lungs of mice inoculated with vG than in those given vN (P, 0.02). Virus was not detected in the spleens of any mice inoculated i.n. with either virus.
Comparison of titres of vG and vF in the lunqs after i.n. inoculation
The ability of vG301 and vF317 (which are structurally similar recombinants) to replicate in the lungs of groups of five mice inoculated i.n. with approximately 1 × 106 p.f.u, of virus was examined. In two experiments (Table  2) , the titre of vG was significantly higher than that of vF in the lungs 5 days after infection (P, 0-03 and 0.01).
Discussion
In order to induce protective immunity throughout the entire respiratory tract it has been shown that administration of recombinant VV by the i.n. route is more effective than by the intradermal route (Small et al., 1985) . In addition, i.n. vaccination with recombinant VV expressing genes encoding F and G of RSV was effective in the face of passively transferred antibody (Murphy et al., 1989) . In contrast, passively transferred antibody suppressed the efficacy of these recombinants administered by the intradermal route (Murphy et al., 1988) . It is therefore important that extensive studies of the biological properties of recombinant viruses inoculated i.n. should be undertaken. It has been shown previously that i.n. inoculation of mice with wt VV strain WR results in a lethal infection (Stott et al., 1986) . Our studies have shown that wt virus grows to high titres in the lungs and can be recovered from non-pulmonary sites 2 days after inoculation. In contrast, i.n. inoculation of mice with tk-recombinants containing the gene for RSV G did not result in a lethal infection, virus grew to lower titres in the lungs than those observed with wt virus and there was little extrapulmonary dissemination of virus. These findings are similar to those observed in mice after i.p. inoculation of tk-recombinants, reported by Buller et al. (1985) , in that there was little spread oftk-virus from the 2.5 ± 0.8 2.9 ± 1.4 1.8 ± 0.3 < 1.7 < 1-7 < 1.7 4.1 ± 1-0 4.3 ± 1.4 (3/5) (4/5) (2/5) (1/5) (0/5) (0/5) (5/5) (5/5) 3 2.7 ± 0.7 2.5 ± 0.6 2.3 ± 1.0 2.0 ± 0.7 < 1.7 < 1.7 4.6 ± 1-7 4.5 ± 0.7 (4/5) (4/5) (2/5) (2/5) (0/5) (0/5) (4/5) (5/5) 4 2.2 ± 1.4 < 1,7 1-8 ± 0.5 < 1-7 < 1.7 < 1-7 6.2 ± 0.6 5.0 ± 0.4 (1/5) (0 site of inoculation. Insertion of the tk gene into vG301 restored its virulence for mice. Thus, i.n. inoculation of mice with tk ÷ recombinant VV resulted in a lethal infection, with titres of virus in the lungs and extrapulmonary tissues similar to those seen in mice infected i.n. with wt virus. These findings confirm that the decreased virulence of tk-recombinant VV is due to inactivation of the tk gene and is not the result of other mutations which might have occurred during selection.
The finding that wt and vG301.208 tk ÷ grew to similar titres in the brain after i.n. inoculation contrasts with the findings of Roizman & Sears (1990) with herpes simplex virus. These workers observed that restoration of the tk gene in a mutant of herpes simplex virus at another site did not increase the neurovirulence of the mutant.
Changes in virus titre in the lungs of mice inoculated i.n. with tk ÷ or wt virus and those inoculated with tkvirus were the same for the first 18 h after infection. After this time, tk-virus grew to lower titres in the lung.
It may be that by 24 h after inoculation there was insufficient thymidine triphosphate in the lungs and this therefore limited replication of the tk-virus to such an extent that host defence mechanisms were subsequently able to control the infection and clear the virus from the lungs.
The finding of virus (albeit at low titres) in the brains of mice inoculated i.n. with vG301.208 tk-gives cause for concern. Although care was taken in obtaining brain tissue to exclude contamination from nasal passages, this possibility cannot be excluded. However, virus has been recovered from one of four mice inoculated 9 days previously, a time when virus was not recovered from the lungs (results not shown). There is a possibility that the viruses recovered from the brains of mice inoculated i.n. with vG301 were tk ÷ revertants. However, reversion to tk ÷ is not possible with vG301.208 tk-as the tk gene is deleted. Virus was isolated from the brains of all mice inoculated i.n. 4 days previously with this virus. The WR strain is a highly pathogenic neurovirulent virus derived from the New York Board of Health strain by serial intracerebral passage in mice. It is possible, therefore, that recombinant VV strain WR may infect the brain of mice more readily than other strains of VV. Further work is needed to determine the extent of infection and pathological changes in the brain of mice inoculated i.n. with recombinants produced from different strains of VV.
There was some evidence to suggest that expression of G by recombinant VV affected the ability of the virus to replicate in the lung. Thus, following i.n. inoculation, two independently derived vG constructs (vG301 and vG301.280 tk-) grew to significantly higher titres than vN or vF in the lungs, whereas after i.p. inoculation, vG301 and vN grew to similar titres in the spleen. The reasons for this are not known but, because the result was observed with two independent vG isolates, it appears that G expression rather than some cryptic difference in the recombinants was responsible. It may be that expression of the attachment protein of RSV facilitates infection of a greater number of cells in the lung.
The present work confirms that the marked reduction in virulence of recombinant VV is due to inactivation of the tk gene. We also highlight a danger of brain infection after i.n. inoculation. This finding, together with that reported previously, of lesions in the lungs of mice inoculated with recombinant VV containing genes for RSV (Stott et al., 1987) , highlights the potential dangers associated with the i.n. inoculation of these viruses.
